Author

Smith Giri

Institutions: University of Alabama at Birmingham, UAB Medicine

Observed institutions: University of Alabama at Birmingham, UAB Medicine

ORCID: 0000-0002-1827-5032

Observed ORCID: 0000-0002-1827-5032

OpenAlex ID: A5123973433

Distinct trajectory of measurable residual disease in t(11;14) myeloma treated with quadruplet therapy

2026 · Susan Bal, Gayathri Ravi, et al. · Blood · 5

Validation of the 2025 IMS / IMWG risk classification in patients with newly diagnosed multiple myeloma treated with quadruplets and autologous stem cell transplant

2026 · Priyanka Venkatesh, Gayathri Ravi, et al. · British Journal of Haematology · 3

Quantitative bias analyses to address measurement error in time-to-event endpoints

2026 · Benjamin Ackerman, Ryan W Gan, et al. · American Journal of Epidemiology · 1

Works count: 3

Citation count: 9

H-index: 2

I10-index: